Phase I study of oral bioflavonoids in cadaveric renal transplant recipients: effects on delayed graft function and calcineurin inhibitor toxicities
- 12 March 2003
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 35 (2) , 841-842
- https://doi.org/10.1016/s0041-1345(02)04038-1
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Mechanism of heme oxygenase-1 gene induction by curcumin in human renal proximal tubule cellsAmerican Journal of Physiology-Renal Physiology, 2001
- Delayed graft functionUrologic Clinics of North America, 2001
- Quercetin, a bioflavonoid, protects against oxidative stress-related renal dysfunction by cyclosporine in ratsMethods and Findings in Experimental and Clinical Pharmacology, 2001
- Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstructionUrology, 2000
- Synergy of mycophenolate mofetil and bioflavonoids in prevention of immune and ischemic injuryTransplantation Proceedings, 2000
- Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stressFree Radical Biology & Medicine, 2000
- Protective effect of heme oxygenase induction in ischemic acute renal failureCritical Care Medicine, 2000
- Oxidant-induced apoptosis of glomerular cells: Intracellular signaling and its intervention by bioflavonoidKidney International, 1999
- EFFECT OF BIOFLAVONOIDS QUERCETIN AND CURCUMIN ON ISCHEMIC RENAL INJURYTransplantation, 1998
- Curcumin Blocks Cyclosporine A-Resistant CD28 Costimulatory Pathway of Human T-Cell ProliferationJournal of Surgical Research, 1998